[Improvement of anemia and quality of life of patients with prostate cancer by treatment with human recombinant erythropoietin].

Article

[Improvement of anemia and quality of life of patients with prostate cancer by treatment with human recombinant erythropoietin].

J.A. Queipo Zaragozá,F. Chicote Pérez,J.F. Beltrán Meseguer,A. Borrell Palanca,Vicente Giner Marco,Jesús Esteve Claramunt+1 more-2004-05-20-PubMed

4

TL;DRAbstract

We consider that the administration of EPO increases significantly the levels of haemoglobin and the quality of life of patients with prostate adenocarcinoma, being the response worse in patients with low levels of baseline haemoglobin.

Chat with Paper

AI Agents for this Paper

We consider that the administration of EPO increases significantly the levels of haemoglobin and the quality of life of patients with prostate adenocarcinoma, being the response worse in patients with low levels of baseline haemoglobin.

Keywords

ErythropoietinMedicineProstate cancerAnemiaQuality of life (healthcare)CancerInternal medicineAdverse effect

Chat

Click to start Chat